Evening Primrose Oil for Premenstrual Syndrome (PMS)

Evidence for evening primrose oil in PMS and cyclical breast pain is weak and mostly negative in higher-quality trials.

Overview

Evidence for evening primrose oil in PMS and cyclical breast pain is weak and mostly negative in higher-quality trials.

Verdict

Insufficient evidence

How It Works

GLA supplementation is proposed to correct an essential fatty acid imbalance affecting prostaglandin-mediated tissue sensitivity to prolactin.

Dosing & Protocol

Typical dose

Recommended dose: 500-1000mg 2-3x daily
Expected timeframe: Trials assessed change over 3-6 menstrual cycles. Most showed no separation from placebo at any point.

Protocol

form: Cold-pressed evening primrose oil softgels standardised to 8-10% gamma-linolenic acid
duration: Studies ran 3-6 menstrual cycles; if a trial is attempted, stop at 3 cycles without clear benefit
co factor: Take with food to reduce nausea; discuss with a clinician if you take anticoagulants or anti-epileptics (seizure-threshold interaction reported with phenothiazines)
titration: No titration is justified — pooled trial data did not separate evening primrose oil from placebo for overall PMS severity
starting dose: Trials used 500-1000 mg evening primrose oil (roughly 40-80 mg GLA) two to three times daily; this is the studied dose, not a recommendation

Evidence

What the studies say

Systematic reviews of cyclical mastalgia and PMS found no consistent benefit over placebo once trial quality was accounted for; UK regulators withdrew licensed indications for lack of efficacy.

The Effect of Oenothera biennis (Evening Primrose) Oil on Inflammatory Diseases: A Systematic Review of Clinical Trials

Score: 6/10

2024

systematic_review

Timoszuk M, Mahboubi M, Sharifi-Rad J

Effects were inconsistent and the strongest trials were largely null; safety was good.

View source

Safety

Caveats

Evidence is insufficient: systematic reviews find no reliable benefit over placebo for general PMS, with a weak and inconsistent signal only for cyclical breast pain. Avoid in pregnancy (insufficient safety data) and use caution with anticoagulants and antiplatelet drugs. Reported to lower seizure threshold in people taking phenothiazines.

Less likely to help if

Most people see no change. Those with premenstrual dysphoric disorder, an underlying mood disorder, or symptoms driven by thyroid disease or perimenopause should be assessed clinically rather than trialling GLA.

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.